CD-3 Immunohistochemistry Test at Lahore PCR Lab

CD-3 Immunohistochemistry at Lahore PCR Lab

CD-3 Immunohistochemistry (IHC) is a highly specialized diagnostic laboratory test performed to identify and characterize T-lymphocytes within tissue specimens. At Lahore PCR Lab, this advanced pathological analysis plays a critical role in the precise diagnosis of hematological malignancies, inflammatory conditions, and autoimmune disorders. The CD3 antigen is a highly specific lineage marker for T-cells, making this immunohistochemical stain an indispensable tool for pathologists. By utilizing monoclonal or polyclonal antibodies directed against the CD3 protein complex, our laboratory can visualize the distribution, density, and morphology of T-lymphocytes under a microscope, providing invaluable diagnostic insights that guide clinical management.

The CD3 antigen is a multi-subunit protein complex closely associated with the T-cell receptor (TCR) on the surface of mature T-lymphocytes and thymocytes. It consists of four distinct polypeptide chains—gamma, delta, and two epsilon chains—that play a vital role in transmitting antigen-recognition signals from the cell surface to the intracellular environment. Because CD3 expression is highly conserved throughout T-cell development and is absent in B-lymphocytes and other non-lymphoid cells, it serves as an exceptionally reliable marker for identifying cells of T-lineage. In the clinical setting, distinguishing between T-cell and B-cell populations is fundamental to classifying lymphoproliferative disorders, diagnosing lymphomas, and evaluating tissue responses to various diseases.

At Lahore PCR Lab, located in Lahore, Pakistan, we employ state-of-the-art automated immunohistochemistry platforms to perform CD-3 staining. This advanced technology ensures optimal antigen retrieval, precise antibody incubation, and highly sensitive detection systems, minimizing background staining and maximizing diagnostic clarity. The primary clinical benefit of CD-3 IHC is its ability to provide definitive lineage identification in complex tissue biopsies where routine hematoxylin and eosin (H&E) staining is insufficient. Whether evaluating a lymph node biopsy, a skin lesion, a gastrointestinal specimen, or a bone marrow trephine, CD-3 IHC delivers the cellular resolution required for accurate medical decision-making.

Clinical Procedure: What to Expect

Patient Preparation

Because CD-3 Immunohistochemistry is a laboratory test performed on tissue specimens that have already been obtained via biopsy or surgical resection, there is no direct preparation required for the patient on the day of the laboratory analysis itself. However, patient preparation is crucial for the primary procedure used to collect the tissue sample. Depending on the site of interest, patients must follow specific clinical guidelines:

• Surgical Biopsies (e.g., Lymph Node, Skin, or Organ Biopsy): Patients may need to fast for a specified number of hours if conscious sedation or general anesthesia is required.
• Medication Adjustments: Under the guidance of their referring physician, patients may need to temporarily discontinue blood-thinning medications (such as aspirin, warfarin, or clopidogrel) to minimize the risk of bleeding during the biopsy procedure.
• Pre-Procedure Hygiene: For skin biopsies, patients should keep the area clean and avoid applying lotions, creams, or cosmetics to the target site.
• Post-Biopsy Care: Following tissue collection, patients must follow local wound care instructions to prevent infection and promote healing at the biopsy site.
• Documentation: Patients must provide complete clinical history, previous pathology reports, and relevant imaging results to Lahore PCR Lab to assist the pathologist in clinical correlation.

During the Procedure

The analytical phase of CD-3 Immunohistochemistry takes place entirely within the histopathology department of Lahore PCR Lab. The procedure involves several highly controlled technical steps executed by skilled histotechnologists and evaluated by consultant pathologists:

• Specimen Reception and Fixation: The tissue specimen obtained from the biopsy is immediately placed in 10% neutral buffered formalin to preserve cellular architecture and prevent autolysis.
• Tissue Processing and Embedding: The fixed tissue undergoes dehydration, clearing, and infiltration with paraffin wax. It is then embedded into a solid paraffin block, which provides structural support for sectioning.
• Microtomy: Ultra-thin sections, typically measuring 3 to 4 micrometers in thickness, are cut from the paraffin block using a precision microtome and mounted onto specialized adhesive glass slides.
• Deparaffinization and Rehydration: The tissue sections on the slides are heated and treated with clearing agents (such as xylene) and graded alcohols to remove the paraffin and rehydrate the tissue.
• Antigen Retrieval: To expose the CD3 epitopes that may have been masked during formalin fixation, the slides undergo Heat-Induced Epitope Retrieval (HIER) using specialized buffer solutions under controlled temperature and pressure.
• Primary Antibody Incubation: The tissue is incubated with a highly specific anti-CD3 primary antibody (monoclonal or polyclonal) that binds precisely to the CD3 antigen on T-lymphocytes.
• Detection and Visualization: A secondary antibody conjugated with an enzyme (such as horseradish peroxidase) is applied, followed by a chromogen substrate (usually 3,3′-diaminobenzidine, or DAB). This chemical reaction produces a visible brown precipitate at the site of CD3 antigen localization.
• Counterstaining and Mounting: The slides are counterstained with hematoxylin to color the cell nuclei blue, dehydrated, cleared, and sealed with a coverslip for microscopic examination.

When is a CD-3 Immunohistochemistry Performed?

Diagnosis of T-Cell Lymphomas

Physicians request CD-3 Immunohistochemistry when they suspect a T-cell malignancy, such as peripheral T-cell lymphoma, anaplastic large cell lymphoma, or cutaneous T-cell lymphoma (mycosis fungoides). Patients presenting with persistent lymphadenopathy, unexplained fever, night sweats, and weight loss often undergo lymph node or skin biopsies. CD-3 IHC allows the pathologist to confirm that the neoplastic cellular infiltrate is of T-cell origin, distinguishing it from B-cell lymphomas or non-lymphoid tumors, which is critical because the therapeutic protocols for T-cell and B-cell malignancies differ significantly.

Classification of Lymphoproliferative Disorders

In cases of atypical lymphoid hyperplasia, where lymph nodes or extranodal tissues show abnormal lymphocytic proliferation, CD-3 IHC is performed to evaluate the architectural distribution of T-cells. Symptoms such as localized swelling, chronic fatigue, or hepatosplenomegaly prompt this investigation. By highlighting the T-cell zones (paracortex) and comparing them with B-cell zones (follicles), the pathologist can determine whether the proliferation is a reactive, benign process or a clonal, neoplastic expansion, thereby guiding subsequent molecular clonality studies.

Evaluation of Inflammatory and Autoimmune Diseases

CD-3 IHC is frequently utilized to assess mucosal biopsies in patients suspected of having autoimmune or chronic inflammatory diseases, such as celiac disease or inflammatory bowel disease (IBD). Patients presenting with chronic diarrhea, malabsorption, abdominal pain, or unexplained weight loss undergo endoscopic biopsies. In celiac disease, CD-3 staining highlights an increase in intraepithelial lymphocytes (IELs) within the duodenal mucosa, a key diagnostic criterion. In other tissues, it helps quantify the severity and character of the inflammatory infiltrate.

Assessment of Organ Transplant Rejection

In patients who have undergone solid organ transplantation (such as kidney, liver, or heart) and exhibit signs of graft dysfunction, CD-3 IHC is performed on allograft biopsies. Clinical symptoms may include decreased urine output, elevated serum creatinine, or localized pain over the graft site. The presence of a dense interstitial infiltrate of CD3-positive T-lymphocytes invading the tubules (tubulitis) or vascular intima (endarteritis) is a hallmark of acute cellular rejection, allowing clinicians to promptly adjust immunosuppressive therapy.

Characterization of Tumor-Infiltrating Lymphocytes (TILs)

Oncologists frequently request CD-3 IHC to evaluate the immune microenvironment of solid tumors, such as colorectal, breast, or lung carcinomas. Patients undergoing surgical resection of tumors have their tissue analyzed for Tumor-Infiltrating Lymphocytes (TILs). The density and spatial distribution of CD3+ T-cells within and around the tumor nest provide crucial prognostic information and help predict the patient’s likelihood of responding to modern cancer immunotherapies, such as immune checkpoint inhibitors.

What Does a CD-3 Immunohistochemistry Detect?

CD-3 Immunohistochemistry is designed to detect the presence, distribution, density, and cellular localization of the CD3 antigen. In a clinical diagnostic setting, this staining technique can identify and characterize a wide range of pathological findings, including:

• Normal T-cell distribution: Identification of healthy T-lymphocytes localized within the paracortex of lymph nodes, periarteriolar lymphoid sheaths of the spleen, and interfollicular areas of tonsils.
• Intraepithelial lymphocytosis: An abnormal increase in CD3+ T-cells within the epithelial layer of mucosal tissues, particularly in the duodenum, indicating celiac disease or microscopic colitis.
• Diffuse neoplastic infiltration: Monomorphic sheets of CD3+ atypical lymphocytes obliterating normal tissue architecture, highly suggestive of T-cell non-Hodgkin lymphoma.
• Epidermotropism: The migration of CD3+ atypical T-lymphocytes into the epidermis of the skin, a classic diagnostic finding in cutaneous T-cell lymphoma (mycosis fungoides).
• Tubulitis: Infiltration of CD3+ T-cells into the renal tubular epithelium, indicating active T-cell mediated rejection in kidney transplants.
• Sinusoidal infiltration: Presence of CD3+ T-cells within the hepatic sinusoids, which can be seen in systemic T-cell lymphomas or viral infections like infectious mononucleosis.
• Tumor-Infiltrating Lymphocytes (TILs): Quantifiable presence of CD3+ T-cells within the stroma or parenchyma of solid tumors, correlating with host immune response.
• Aberrant antigen loss: Neoplastic T-cells that fail to express CD3, a common finding in poorly differentiated T-cell lymphomas that helps confirm malignancy.
• Perivascular lymphocytic cuffing: Accumulation of CD3+ T-cells around blood vessels in brain or skin biopsies, indicating autoimmune or infectious encephalitis/dermatitis.
• Granulomatous inflammation: CD3+ T-cells forming a peripheral ring around epithelioid histiocytes in granulomas, characteristic of tuberculosis or sarcoidosis.
• Follicular helper T-cells: CD3+ T-cells located within germinal centers, assisting in the evaluation of angioimmunoblastic T-cell lymphoma.
• Bystander T-cell populations: A rich background of reactive CD3+ T-cells surrounding neoplastic B-cells or Reed-Sternberg cells in Hodgkin lymphoma.
• Bone marrow infiltration: Focal or diffuse interstitial aggregates of CD3+ T-cells in bone marrow trephine biopsies, helping evaluate involvement by T-cell leukemia/lymphoma.
• Lichenoid tissue reaction: A band-like infiltrate of CD3+ T-cells at the dermo-epidermal junction, characteristic of lichen planus or lichenoid drug eruptions.
• Myocarditis: Infiltration of CD3+ T-cells into the myocardial interstitium associated with myocyte necrosis, confirming inflammatory heart disease.
• Autoimmune thyroiditis: Dense aggregates of CD3+ T-cells destroying thyroid follicles in Hashimoto’s thyroiditis.
• Sialadenitis: CD3+ lymphocytic infiltration of salivary gland parenchyma in Sjögren’s syndrome.
• Pleural/peritoneal fluid involvement: CD3+ T-cells in cell block preparations of cytological effusions, helping differentiate reactive effusions from lymphoma.
• Atypical lobular panniculitis: CD3+ T-cells rimming adipocytes in subcutaneous fat, seen in subcutaneous panniculitis-like T-cell lymphoma.
• Normal thymic populations: Strong, diffuse CD3 expression in mature medullary thymocytes and variable expression in cortical thymocytes.

Turnaround Time and Report Access at Lahore PCR Lab

At Lahore PCR Lab, we understand that timely diagnostic results are critical for patient management, particularly when malignancy or transplant rejection is suspected. The turnaround time for CD-3 Immunohistochemistry is typically 3 to 5 working days from the receipt of the tissue specimen or paraffin block. This timeframe allows for meticulous tissue processing, sectioning, automated staining, quality control checks, and detailed microscopic evaluation by our consultant pathologists.

Lahore PCR Lab offers convenient digital access to diagnostic reports. Once the consultant pathologist signs off on the final report, patients and their referring physicians receive an automated SMS notification. Reports can be viewed, downloaded, and printed directly from our secure online patient portal. Additionally, patients can access their reports via our dedicated WhatsApp service or collect a high-quality printed copy from our main facility or any of our collection centers across Lahore. This seamless reporting process ensures that oncologists, hematologists, and surgeons can initiate appropriate clinical interventions without delay.

CD-3 Immunohistochemistry Findings Overview

The following table provides an overview of the typical parameters evaluated during CD-3 Immunohistochemistry, comparing normal physiological findings with possible pathological abnormalities:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Lymph Node Paracortex	Moderate to dense population of small, cytologically bland CD3+ T-cells.	Marked expansion or complete effacement by atypical, pleomorphic CD3+ neoplastic cells.
Duodenal Mucosa	Low number of intraepithelial CD3+ lymphocytes (<20 per 100 enterocytes).	Significant increase in intraepithelial CD3+ lymphocytes (>25 per 100 enterocytes), indicating celiac disease.
Renal Allograft Tubules	No or minimal CD3+ T-cell infiltration within the tubular epithelium.	Presence of multiple CD3+ T-cells invading tubular basement membranes (tubulitis), indicating acute cellular rejection.
Skin Dermis and Epidermis	Scattered CD3+ T-cells in the superficial dermis; rare or absent in the epidermis.	Band-like dermal infiltrate or CD3+ T-cells migrating into the epidermis (epidermotropism), indicating mycosis fungoides.
Tumor Microenvironment	Variable presence of stromal CD3+ T-cells depending on tumor type.	Dense intratumoral CD3+ T-cell infiltration (high TILs), often associated with a favorable prognosis and immunotherapy response.
Lymphoid Follicles	CD3+ T-cells restricted to the interfollicular zones; very few within germinal centers.	Abnormal accumulation of CD3+ T-cells within germinal centers, seen in angioimmunoblastic T-cell lymphoma.
Bone Marrow Interstitium	Scattered, individual CD3+ T-cells without forming large aggregates.	Dense focal aggregates or diffuse interstitial infiltration of CD3+ T-cells, indicating bone marrow involvement by lymphoma.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for CD-3 Immunohistochemistry?

• Experienced healthcare professionals: Our pathology department is led by highly qualified consultant pathologists with extensive experience in histopathology and immunohistochemistry.
• Patient-focused care: We prioritize patient comfort and convenience, offering clear guidance throughout the diagnostic process.
• Quality diagnostic services: Lahore PCR Lab adheres to strict internal and external quality control protocols to ensure the highest accuracy of all IHC stains.
• Professional reporting: Our reports provide detailed, comprehensive diagnostic descriptions, including clinical correlation and relevant immunohistochemical profiles.
• Modern diagnostic approach: We utilize state-of-the-art automated staining platforms that minimize human error and deliver consistent, reproducible results.
• Comfortable environment: Our collection centers and main laboratory in Lahore are designed to provide a clean, safe, and welcoming environment for patients.
• Convenient location: Situated centrally in Lahore, our facility is easily accessible for patients and courier services delivering tissue specimens.
• Commitment to accurate diagnosis: We understand the critical nature of pathology reports and are dedicated to delivering precise results that clinicians can trust for treatment planning.